Algernon Pharmaceuticals Inc (AGNPF)

[medchem]

As someone pointed out recently, it's an open label trial. So the doctors enrolling patients and treating them probably went back to the company and said people are doing really well. The reason for an early release? Secure major funding from big pharma for phase 3 (i.e. a partner) and also get the process for emergency access approval from the FDA started EARLIER. Why wait.